Citadel Advisors
NRX

Citadel Advisors’s NEPHROGENEX INC COM NRX Stock Holding History

Citadel Advisors’s Portfolio NRX Stock Details NRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-38,899
Closed -$18K – 7908
2016
Q1 		$18K Buy
+38,899
New +$32.3K ﹤0.01% 6505

Citadel Advisors's NRX Position: Q2 2016 in Review

Citadel Advisors sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 38,899 shares — an estimated $18K sold.

Citadel Advisors first reported a position in NRX in Q1 2016 and held it in 1 quarter. The position peaked at $18K in Q1 2016. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

  • Citadel Advisors reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
  • Citadel Advisors sold 38,899 NEPHROGENEX INC COM shares in Q2 2016, an estimated $18K.
  • Citadel Advisors first reported a position in NEPHROGENEX INC COM in Q1 2016 and held it in 1 quarter.
  • Citadel Advisors's NEPHROGENEX INC COM position peaked at $18K in Q1 2016.
  • 1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.